Cibus, Inc. (CBUS)
1.455
-0.14
(-8.49%)
USD |
NASDAQ |
Apr 08, 13:38
Cibus EPS Diluted (Quarterly) : -0.5886 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | -0.2458 |
| Protalix Biotherapeutics, Inc. | -0.0684 |
| InspireMD, Inc. | -0.1428 |
| CytomX Therapeutics, Inc. | -0.1734 |
| Pelthos Therapeutics, Inc. | -6.868 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.95M |
| Revenue (Quarterly) | 1.057M |
| Total Expenses (Quarterly) | 32.34M |
| Enterprise Value | 379.16M |
| Gross Profit Margin (Quarterly) | -30.09% |
| Profit Margin (Quarterly) | -3.02K% |
| Earnings Yield | -246.1% |
| Normalized Earnings Yield | -200.89 |